selected publications academic article Tyagi, B., Chandrasekaran, B., Tyagi, A., Shukla, V., Saran, U., Tyagi, N., ... Damodaran, C. (2023). Exposure of environmental trace elements in prostate cancer patients: A multiple metal analysis. TOXICOLOGY AND APPLIED PHARMACOLOGY. 479, 116728-116728. Tyagi, A., Chandrasekaran, B., Navin, A. K., Shukla, V., Baby, B. V., Ankem, M. K., & Damodaran, C. (2023). Molecular interplay between NOX1 and autophagy in cadmium-induced prostate carcinogenesis. Free Radical Biology and Medicine. 199, 44-55. Chandrasekaran, B., Tapadar, S., Wu, B., Saran, U., Tyagi, A., Johnston, A., ... Damodaran, C. (2023). Antiandrogen-Equipped Histone Deacetylase Inhibitors Selectively Inhibit Androgen Receptor (AR) and AR-Splice Variant (AR-SV) in Castration-Resistant Prostate Cancer (CRPC). Cancers. 15(6), 1769-1769. Saran, U., Chandrasekaran, B., Tyagi, A., Shukla, V., Singh, A., Sharma, A. K., & Damodaran, C. (2023). A small molecule inhibitor of Notch1 modulates stemness and suppresses breast cancer cell growth. Frontiers in Pharmacology. 14, 1150774. Chandrasekaran, B., Tyagi, A., Saran, U., Kolluru, V., Baby, B. V., Chirasani, V. R., ... Damodaran, C. (2023). Urolithin A analog inhibits castration-resistant prostate cancer by targeting the androgen receptor and its variant, androgen receptor-variant 7. Frontiers in Pharmacology. 14, 1137783. Shukla, V., Chandrasekaran, B., Tyagi, A., Navin, A. K., Saran, U., Adam, R. M., & Damodaran, C. (2022). A Comprehensive Transcriptomic Analysis of Arsenic-Induced Bladder Carcinogenesis. Cells. 11(15), 2435-2435. Singh, A., Raza, A., Amin, S., Damodaran, C., & Sharma, A. K. (2022). Recent Advances in the Chemistry and Therapeutic Evaluation of Naturally Occurring and Synthetic Withanolides. Molecules. 27(3), 886-886. Saran, U., Tyagi, A., Chandrasekaran, B., Ankem, M. K., & Damodaran, C. (2021). The role of autophagy in metal-induced urogenital carcinogenesis. Seminars in Cancer Biology. 76, 247-257. conference paper Shukla, V., Tyagi, A., Kolluru, V., Saran, U., Chandrasekaran, B., Ankem, M. K., & Damodaran, C. (2022). Activation of NFKB is responsible for defective autophagy in cadmium-induced transformation of prostate cells. Cancer Research. Saran, U., Chandrasekaran, B., Tyagi, A., Tapadar, S., Wu, B., Adegboyega, O., & Damodaran, C. (2022). Developing a multifaceted approach to target androgen receptor (AR) in castration resistant prostate cancer. Cancer Research. Saran, U., Chandrasekaran, B., Tyagi, A., Singh, A., Ankem, M. K., Sharma, A. K., & Damodaran, C. (2022). Discovery of a small molecule inhibitor for triple-negative breast cancer (TNBC). Cancer Research. Navin, A. K., Shukla, V., Chandrasekaran, B., Tyagi, A., Saran, U., Ankem, M. K., & Damodaran, C. (2022). Molecular landscape of arsenic-induced bladder carcinogenesis. Cancer Research. Tyagi, A., Chandrasekaran, B., Saran, U., Ankem, M. K., Dokholyan, N., Lin, J. M., Sharma, A. K., & Damodaran, C. (2022). Selective ubiquitination of androgen receptor and its splice variants inhibits castration resistant prostate cancer. Cancer Research.
teaching activities BIOT684 Directed Prof Internshp Instructor BIOT685 Directed Studies Instructor PHSC685 Directed Studies Instructor PHSC691 Research Instructor
